Downregulation of SMAD2, 4 and 6 mRNA and TGFβ receptor I mRNA in lesional and non-lesional psoriatic skin

Acta Dermato-Venereologica

Volumn 89, Issue 4, 2009, Pages 351-356

  Yu, Haiyan ^a   Mrowietz, Ulrich ^b   Seifert, Oliver ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

Psoriasis; SMAD; TGFbeta

Indexed keywords

MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PSORIASIS; PUNCH BIOPSY; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; DOWN-REGULATION; FEMALE; HUMANS; MALE; PROTEIN-SERINE-THREONINE KINASES; PSORIASIS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD4 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 69249115300     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0634     Document Type: Article

References (27)

1. Capon F, Munro M, Barker J, Trembath R. Searching for the major histocompatibility complex psoriasis susceptibility gene. J Invest Dermatol 2002; 118: 745-751. (Pubitemid 34526535)
2. Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L, et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL 12B) confer protection against psoriasis. Hum Genet 2007; 122: 201-206. (Pubitemid 47241785)
3. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80: 273-290. (Pubitemid 46175676)
4. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-873.
5. Schröder JM, Harder J. Antimicrobial skin peptides and proteins. Cell Mol Life Sei 2006; 63: 469-486.
6. Doi H, Shibata MA, Kiyokane K, Otsuki Y. Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris. J Dermatol Sei 2003; 33: 7-16. (Pubitemid 37188472)
7. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-584. (Pubitemid 37280136)
8. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999; 1: 260-266. (Pubitemid 129495775)
9. Yanagi Y, Suzawa M, Kawabata M, Miyazono K, Yanagisawa J, Kato S. Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J Biol Chem 1999; 274: 12971-12974. (Pubitemid 129518492)
10. Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, et al. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 1999; 283: 1317-1321.
11. Oyama N, Iwatsuki K, Satoh M, Akiba H, Kaneko F. Dermal fibroblasts are one of the therapeutic targets for topical application of 1 alpha,25- dihydroxyvitamin D3: the possible involvement of transforming growth factor-beta induction. Br J Dermatol 2000; 143: 1140-1148. (Pubitemid 32052747)
12. Bustin SA. Absolute quantification of mRNA using realtime reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25: 169-193.
13. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-1358. (Pubitemid 30408720)
14. Nockowski P, Szepietowski JC, Ziarkiewicz M, Baran E. Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris. Acta Dermatovenerol Croat 2004; 12:2-6. (Pubitemid 38524290)
15. Flisiak I, Porebski P, Flisiak R, Chodynicka B. Plasma transforming growth factor betal as a biomarker of psoriasis activity and treatment efficacy. Biomarkers 2003; 8: 437-443. (Pubitemid 37509176)
16. Wataya-Kaneda M, Hashimoto K, Kato M, Miyazono K, Yoshikawa K. Differential localization of TGF-beta-precursor isotypes in psoriatic human skin. J Dermatol Sei 1996; 11: 183-188. (Pubitemid 26077180)
17. Cai JP, Falanga V, Taylor JR, Chin YH. Transforming growth factor-beta receptor binding and function are decreased in psoriatic dermal endothelium. J Invest Dermatol 1996; 106: 225-231. (Pubitemid 26094609)
18. Li AG, Lu SL, Han G, Hoot KE, Wang XJ. Role of TGFbeta in skin inflammation and carcinogenesis. Mol Carcinog 2006; 45: 389-396. (Pubitemid 43865845)
19. Moses HL. TGF-beta regulation of epithelial cell prolife-ration. Mol Reprod Dev 1992; 32: 179-184.
20. Kane CJ, Knapp AM, Mansbridge JN, Hanawalt PC. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ. J Cell Physiol 1990; 144: 144-150. (Pubitemid 20221191)
21. Quan T, He T, Kang S, Voorhees JJ, Fisher GJ. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo. J Invest Dermatol 2002; 119:499-506. (Pubitemid 35001963)
22. Choi CP, Kim YI, Lee JW, Lee MH. The effect of narrowband ultraviolet B on the expression of matrix metal-loproteinase-1, transforming growth factor-beta1 and type I collagen in human skin fibroblasts. Clin Exp Dermatol 2007; 32: 180-185.
23. Occleston NL, Laverty HG, O'Kane S, Ferguson MW. Prevention and reduction of scarring in the skin by transforming growth factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical. J Biomater Sei Polym Ed 2008; 19: 1047-1063. (Pubitemid 351957390)
24. Flisiak I, Chodynicka B, Porebski P, Flisiak R. Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions. Cytokine 2002; 19: 121-125.
25. Li AG, Wang D, Feng XH, Wang XJ. Latent TGFbetal over-expression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J 2004; 23: 1770-1781. (Pubitemid 38649640)
26. Leivo T, Leivo I, Kariniemi AL, Keski-Oja J, Virtanen I. Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis. Br J Dermatol 1998; 138: 57-62. (Pubitemid 28077938)
27. Quan T, He T, Voorhees JJ, Fisher GJ. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7. J Biol Chem 2001; 276: 26349-26356. (Pubitemid 37412852)